NEW YORK, Nov. 23 (GenomeWeb News) - Shares in Nanogen were up 5.24 percent at $4.02 in heavy mid-afternoon trading as investors cheered a new patent the company won in the United States for DNA microarrays.

 

The stock briefly climbed to $4.20 earlier in the day, and trading volume hovered around 1.4 million shares, almost two-and-a-half times their average volume.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.